Name
Plenary 2: Novel therapies - challenges and opportunities
Date & Time
Thursday, April 1, 2027, 10:30 AM - 12:00 PM
Speakers
Simon Fletcher, Gilead Sciences, Inc.
Stephan Urban, University of Heidelberg, Molecular Virology
Ulrike Protzer, Technical University of Munich / Helmholtz Munich
Yuchen Xia, Wuhan University
Mark Sulkowski, Johns Hopkins University School of Medicine
Stephan Urban, University of Heidelberg, Molecular Virology
Ulrike Protzer, Technical University of Munich / Helmholtz Munich
Yuchen Xia, Wuhan University
Mark Sulkowski, Johns Hopkins University School of Medicine
Talk Titles
10:30 - 10:50 Options for HBV / HDV targeting drugs
10:50 - 11:10 New developments in treating viral hepatitis - where does industry go?
11:10 - 11:30 What is required to implement a new therapy?